KLOW

KLOW represents a multi-component peptide research formulation combining GHK-Cu (copper peptide), BPC-157 (pentadecapeptide), Thymosin beta-4(TB-500) (43-amino acid polypeptide), and KPV (tripeptide) in a synergistic research blend. This combination provides researchers with a comprehensive platform for investigating tissue repair mechanisms, anti-inflammatory pathways, copper-peptide interactions, and cellular regeneration processes. The formulation is designed for research applications examining multi-modal peptide interactions and combined therapeutic mechanisms in laboratory systems.